comparemela.com

Latest Breaking News On - Akash mhaskar - Page 1 : comparemela.com

Global Gene Editing Technologies Market to Reach $16 37 Billion by 2032 - Exclusive DeepTech M-A-P Analysis by BIS Research

The increased demand for treatments is fuelling the expansion of gene editing technology manufacturers and providing them with numerous opportunities to spread out across different regions and

Akash mhaskarGewinn nurGene editing services segmentMerck kgaaEngland biolabs incIonis pharmaceuticals incResearch incPrecision biosciences incMagento incDanaher corporationGenecopoeia incTakara bio incThermo fisher scientific incIntellia therapeutics incMerck kgaSangamo therapeutics inc

Global Gene Editing Technologies Market to Reach $16 37 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research

/PRNewswire/ BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Gene Editing.

Akash mhaskarMerck kgaaGenecopoeia incPerkinelmer incPrecision biosciences incTakara bio incIntellia therapeutics incGene editing services segmentDanaher corporationIonis pharmaceuticals incThermo fisher scientific incSangamo therapeutics incTrends in life sciencesEngland biolabs incDrug administrationResearch inc

Global Multicancer Screening Market to Reach $7 78 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research

/PRNewswire/ BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Multicancer.

United statesAkash mhaskarThermo fisher scientific incIllumina incInvitae corporationTechnologies incRoche ltdGuardant health incKonica minolta incDanaher corporationGenetics incGenecast biotechnology co ltdLaboratory corporation of america holdingsAgilent technologies incSciences corporationResearch inc

Global Multicancer Screening Market to Reach $7 78 Billion by 2032 - Exclusive DeepTech M-A-P Analysis by BIS Research

New discoveries of specific biomarkers related to various cancer types are increasing researchers' trust in multicancer sequencing. FREMONT, Calif., April 28, 2023 /PRNewswire/ BIS Research

United statesAkash mhaskarSciences corporationIllumina incGuardant health incGenecast biotechnology co ltdThermo fisher scientific incRoche ltdResearch incAtara biotherapeutics incGenetics incLaboratory corporation of america holdingsInvitae corporationAgilent technologies incTechnologies incKonica minolta inc

Global Cell-Based Assay Market to Reach $38 23 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research

/PRNewswire/ BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Cell-Based Assay.

United statesAkash mhaskarCorning incorporatedBio rad laboratories incLonza groupThermo fisher scientific incMerck kgaCell signaling technology incBiopharma companiesCharles river laboratories international incDanaher corporationAgilent technologies incLaboratory corporation of america holdingsResearch incPromega corporationPerkinelmer inc

vimarsana © 2020. All Rights Reserved.